emtricitabine/rilpivirine/ tenofovir alafenamide

Details

Files
Generic Name:
emtricitabine/rilpivirine/ tenofovir alafenamide
Project Status:
Complete
Therapeutic Area:
HIV-1 infection
Manufacturer:
Gilead Sciences Canada, Inc.
Call for patient/clinician input open:
Brand Name:
Odefsey
Project Line:
Reimbursement Review
Project Number:
SR0507-000
Call for patient/clinician input closed:
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
HIV-1 infection
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: